SpineAlign Medical, Inc.

SpineAlign Medical Inc. is an early-stage medical device company dedicated to improving patient outcomes through the development of innovative, minimally-invasive products to treat disorders of the spine. SpineAlign Medical’s first technology is a nitinol implant designed to improve the treatment of vertebral compression fractures in the thoracic or lumbar spine. These fractures most frequently occur in patients suffering from osteoporosis. The VerteLift™ Implant is CE marked and is in commercial distribution in Europe. The VerteLift Implant is not yet available for sale in the United States; it is currently in an Investigational Device Exemption Trial (IDE Trial). The dedicated SpineAlign Team is committed to advancing minimally invasive treatment of spinal disorders and is currently developing additional technologies to meet emerging clinical needs.